Business Results for Fiscal 2017
(From April 1, 2017 to March 31, 2018)

from the beginning

Business Results for Fiscal 2017 (From April 1, 2017 to March 31, 2018）

• Roadmap to Realizing Long-Term Vision

Business Results for Fiscal 2017

• Consolidated Performance for Fiscal 2017

• Key Points in Performance

• Factors in Increase/Decrease of Operating Profit

• Financial Condition

• Cash Flow Position

Initiatives for & Progress in Tackling Strategic Issues

• 1. Expansion and stable growth in the Kampo market
  Sales perfomance of prescription Kampo products

• 1. Expansion and stable growth in the Kampo market
  Important Domains（Elderly, Cancer, Female）Three Drug-fostering Formulations: Sales Performance

• 1. Expansion and stable growth in the Kampo market
  FY2017 Sales Measures(Focus on the field of gastroenterology)

• 1. Expansion and stable growth in the Kampo market
  FY2017 Key Factors for Underperforming Sales (Rikkunshito)

• 1. Expansion and stable growth in the Kampo market
  FY2018Measures for Rikkunshito Target Facilities

• 1. Expansion and stable growth in the Kampo market
  Market trends (value) for gastrointestinal prokinetic agents

• 1. Expansion and stable growth in the Kampo market
  Market trends (volume) for gastrointestinal prokinetic agents

• 1. Expansion and stable growth in the Kampo market
  FY2018 Sales Measures (1) Gastroenterology Strategy

• 1. Expansion and stable growth in the Kampo market
  Summary of DREAM Study Results

• 1. Expansion and stable growth in the Kampo market
  FY2018 Sales Measures: Specific measures to expand market for Rikkunshito

• 1. Expansion and stable growth in the Kampo market
  FY2017 Growing Formulations (Mechanisms)

• 1. Expansion and stable growth in the Kampo market
  FY2018 Sales Measures (2) Kampo BPSD Network Strategy

• 1. Expansion and stable growth in the Kampo market
  FY2018 Sales Measures (3) Other strategies

• 1. Expansion and stable growth in the Kampo market
  FY2018 Sales Measures: GP seminars (Kampo base camp)

• 1. Expansion and stable growth in the Kampo market
  Percentage of Doctors Prescribing Kampo

• 1. Expansion and stable growth in the Kampo market
  OTC Kampo Formulations: Renewal of the Tsumura KampoSeries (March 2018)

• 2. Continued reinforcement of profitability and maximization of cash flow
  Crude Drug Prices

• 2. Continued reinforcement of profitability and maximization of cash flow
  Improve Labor Productivity

• 2. Continued reinforcement of profitability and maximization of cash flow
  Inventory Asset Trends

• 3. Taking on the challenge of new businesses in China
  Progress in China Business

Status of Development in the United States

• Summary of US Development of TU-100 (Daikenchuto)

• Summary of US Development of TU-100

• Policy Going Forward for US Development of TU-100

• Results Obtained from US Development of TU-100

Topics for ESG Activities

• Transformation of Corporate Governance Structure

• Measures to Improve the Efficacy of the Board of Directors

• Corporate FurusatoNozeiProgram (Yubari City)

FY2018 Performance Forecasts

• FY2018 Performance Forecasts

Return of Profits to Shareholders

• Return of Profits to Shareholders

@